Efficacy of biofeedback in the treatment of migraine and tension type headaches
- PMID: 19935987
Efficacy of biofeedback in the treatment of migraine and tension type headaches
Abstract
Background: Biofeedback is an established non-pharmacologic technique commonly used in the treatment of migraine and tension type headaches. Multiple published studies have suggested that biofeedback is effective in reducing the frequency and severity of headaches, often allowing patients to decrease their dependence on medication. Studies have also suggested that biofeedback may effect a decrease in medical utilization.
Objective: Assess the efficacy of biofeedback in reducing the frequency and severity of migraine and tension type headaches.
Design: Randomized, prospective, single blind, single center controlled trial.
Methods: Sixty-four patients with migraine with or without aura and/or tension type headaches, by ICHD-1 criteria, age 18 to 55, who had suffered from headaches for more than one year, were entered into the study. Patients were randomly assigned to receive biofeedback in addition to the basic relaxation instruction or relaxation techniques alone. All patients received instruction in pain theory. Biofeedback training consisted of 10 50-minute sessions utilizing standard EMG feedback from the frontalis and trapezius muscles and temperature from the third finger of the dominant hand. Visual and auditory feedback was provided. Thirty-three patients were assigned to receive biofeedback plus the relaxation techniques and 31, the relaxation techniques alone. All patients were asked to respond to periodic questionnaires for 36 months. The primary analysis was an intention-to-treat (ITT) analysis. The subsidiary analyses were not and the 11 subjects (7 in the relaxation alone and 4 in the biofeedback group) who received no treatment at all were analyzed and the results were qualitatively the same.
Results: Patients who completed the program with education in pain theory and relaxation techniques showed a statistically significant decrease in the frequency and severity of the headaches in the first 12 months that continued to 36 months. Biofeedback provided no additional benefit, specifically no change in the frequency or severity of the headaches. After 3 months 48% of those in the relaxation group reported fewer severe headaches, while 35% of those in the biofeedback group reported fewer severe headaches; after 6 months, 52% of those in the relaxation group reported fewer severe headaches as compared with 57% reporting fewer severe headaches in the biofeedback group. The number of medications used by the patients and the utilization of medical care decreased in both groups over 36 months suggesting a regression to the mean.
Limitations: Compliance was an issue throughout the study. Patients dropped out from the outset and that increased over time. Recovery of questionnaires was difficult and fewer were completed at each 3-month interval. Lack of a large control group who did not receive biofeedback or instruction in relaxation techniques.
Conclusion: Biofeedback is an extremely costly and time-consuming treatment modality that, in our study, provided no additional benefit when compared to simple relaxation techniques alone, in the treatment of migraine and tension type headaches in adults.
Comment in
-
Efficacy of biofeedback in the treatment of migraine and tension type headaches.Pain Physician. 2010 Jan-Feb;13(1):94-6; author reply 96. Pain Physician. 2010. PMID: 20119470 No abstract available.
Similar articles
-
Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.Headache. 2005 Apr;45(4):315-24. doi: 10.1111/j.1526-4610.2005.05068.x. Headache. 2005. PMID: 15836567 Clinical Trial.
-
Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.Headache. 2008 Jun;48(6):900-13. doi: 10.1111/j.1526-4610.2007.00953.x. Epub 2007 Nov 28. Headache. 2008. PMID: 18047501 Clinical Trial.
-
Biofeedback treatment for headache disorders: a comprehensive efficacy review.Appl Psychophysiol Biofeedback. 2008 Sep;33(3):125-40. doi: 10.1007/s10484-008-9060-3. Epub 2008 Aug 26. Appl Psychophysiol Biofeedback. 2008. PMID: 18726688
-
Biofeedback in headache: an overview of approaches and evidence.Cleve Clin J Med. 2010 Jul;77 Suppl 3:S72-6. doi: 10.3949/ccjm.77.s3.13. Cleve Clin J Med. 2010. PMID: 20622082 Review.
-
Acupuncture for tension-type headaches and migraine.Drug Ther Bull. 2010 Jun;48(6):62-5. doi: 10.1136/dtb.2010.02.0016. Drug Ther Bull. 2010. PMID: 20530027 Review.
Cited by
-
sEMG Biofeedback for Episodic Migraines: A Pilot Randomized Clinical Trial.Appl Psychophysiol Biofeedback. 2024 Jun;49(2):271-279. doi: 10.1007/s10484-023-09615-0. Epub 2024 Jan 27. Appl Psychophysiol Biofeedback. 2024. PMID: 38280149 Clinical Trial.
-
Headaches treatment with EMG biofeedback: a focused systematic review and meta-analysis.Eur J Phys Rehabil Med. 2023 Dec;59(6):697-705. doi: 10.23736/S1973-9087.23.07745-6. Epub 2023 Oct 12. Eur J Phys Rehabil Med. 2023. PMID: 37823248 Free PMC article.
-
A Multimodal Conservative Approach to Treating Migraine: A Physical Therapist's Perspective.Curr Pain Headache Rep. 2023 Sep;27(9):329-337. doi: 10.1007/s11916-023-01140-3. Epub 2023 Jul 29. Curr Pain Headache Rep. 2023. PMID: 37515744 Review.
-
Psychological therapies for the prevention of migraine in adults.Cochrane Database Syst Rev. 2019 Jul 2;7(7):CD012295. doi: 10.1002/14651858.CD012295.pub2. Cochrane Database Syst Rev. 2019. PMID: 31264211 Free PMC article.
-
The Four-Cluster Spectrum of Mind-Body Interrelationships: An Integrative Model.Front Psychiatry. 2019 Mar 1;10:39. doi: 10.3389/fpsyt.2019.00039. eCollection 2019. Front Psychiatry. 2019. PMID: 30881314 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous